EMBL Rome
Posted: 2026-06-02 - Rome, ITA
Search More Openings
Join a pioneering in vivo epigenome editing program using CRISPR-based technologies to modulate gene expression in the liver. This role offers exposure to both academic and industry environments, focusing on therapeutic development and team leadership.